In medical news:

Roberto Ceniceros, comp columnist for Risk & Insurance, wrote about the rise of data analytics to monitor whether or not doctors are appropriately utilizing urine drug testing for patients taking opioid medication. Coventry and the Workers’ Compensation Research Institute are among those who welcome the change.

Read the article here.

Leave a Comment

Your email address will not be published. Required fields are marked *